Friday Forums: 2015-2016
_________________________________________
Date: May 15, 2015 – Fellows Forum
Speakers and Topics:
- Hala B AlEssa, ScD – “Carbohydrate Quality and Quantity and Risk of Type 2 Diabetes among US Women”
- Patrick R. Lawler, MD — “Atherogenic Lipoprotein Determinants of Incident Cardiovascular Disease and Residual Risk: A 1H Nuclear Magnetic Resonance Spectroscopy Analysis of the JUPITER Trial”
- Wenyuan Li, SM — “Short-Term Exposure to Air Pollution and Biomarkers of Oxidative Stress: The Framingham Heart Study”
- Mercedes Sotos Prieto, PhD — “Changes in Diet Quality Scores and Risk of Cardiovascular Disease among US Men and Women”
Wines: (1) 2012 J. Christopher Pinot Noir, Willamette Valley, Oregon (2) 2012 Whitehall Lane Merlot, Napa Valley, CA
_________________________________________
Date: September 21, 2015
Speaker: Joachim H. Ix, MD, MAS — Professor and Chief, Division of Nephrology-Hypertension, University of California San Diego
Topic: “Expanding the Assessment of Kidney Health to Inform Relationships between Kidney and Cardiovascular Disease”
Wines: (1) 2012 Ridge Three Valleys, Sonoma County, California (2) 2013 Terra Valentine Cabernet Sauvignon, Napa Valley, California,
_________________________________________
Date: October 30, 2015
Speaker: Edith J.M. Feskens, PhD — Chair of Epidemiology & Public Health, Wageningen University The Netherlands
Topic: “Flavonoids, CHD and Stroke: Latest Updates from Dutch Studies”
Wines: (1) 2012 Domaine de Mourchon Seguret, Rhone, France (2) 2010 Tolaini Al Passo, Tuscany, Italy
_________________________________________
Date: December 11, 2015
Speaker: Ankur Pandya, MPH, PhD
Topic: “Statins, Value, and Values”
Wines: (1) 2013 Warwick—Old Bush, Stellenbosch, South Africa (2) 2013 Kali Hart Pinot Noir, Monterey, California
_________________________________________
Date: February 5, 2016
Speaker: Jeff D. Williamson, MD, MHS — Chief of Gerontology and Geriatric Medicine, Wake Forest University School of Medicine
Topic: “The Systolic Blood Pressure Intervention Trial (SPRINT): Implications for elderly patients”
Wines: (1) 2014 Dönnhoff Kreuznacher Kabinett, Nahe, Germany (2) 2013 Pinot Noir, Willamette Valley, Oregon
_________________________________________
Date: April 15, 2016 – Fellows Forum
Speakers and Topics:
- Jiantao Ma, PhD, MBBS — “DNA Methylation Signatures of Severe Non-alcoholic Fatty Liver Disease”
- Dong Wang, BS, MS — “Lipidomics Profiling, Mediterranean Diet and Cardiovascular Disease Risk in the PREDIMED Trial“
- Rachel Zack, ScM — “Determinants of High Blood Pressure and Barriers to Treatment among Adults in Dar es Salaam, Tanzania“
- Geng Zong, PhD — “Intake of Even-chain Saturated Fatty Acids and Risk of Coronary Heart Disease among U.S. Men and Women“
Wines: (1) 2006 Vina Aquitania Lazuli Cabernet Sauvignon, Maipo, Chile (2) 2013 Achaval Ferrer Malbec, Mendoza, Argentina
_________________________________________
Date: June 3, 2016
Speaker: Jorge R. Kizer, MD, MSc, FACC, FAHA, FASE — Director, Clinical Cardiovascular Research, Department of Medicine, Associate Professor of Medicine and Associate Professor of Epidemiology and Population Health, Albert Einstein College of Medicine
Topic: “Advanced Glycation Endproducts and Micro/Macrovascular Complications: Looking Beyond the Diabetes Realm”
Wines: (1) 2013 Sasso Di Sole Rosso Di Montalcino, Italy (2) 2010 Potensac Medoc, France
_________________________________________
